Biological Sciences
Salk and TSRI findings on long-lived proteins may lead to better understanding of the molecular basis of aging.
| 3 min read
VelaLabs, a provider of analytical services to the global biopharmaceutical industry, and Evercyte, a producer of standardized, relevant cell systems, today (Sept. 3) announced that they have entered into a cooperation to commercialize immortalized target cells for the characterization of biosimilars in a GMP environment.
| 1 min read
Darwin referred to the origin of species as "that mystery of mysteries," and even today, more than150 years later, evolutionary biologists cannot fully explain how new animals and plants arise.
| 3 min read
Researchers have created a model that may explain the complexities of the origins of life. Their work, which appears in the Journal of the Royal Society Interface, offers new insights into how RNA signaling likely developed into the modern “genetic code.”
| 2 min read
Orbitrap Fusion Tribrid LC-MS technology to power new cellular signaling network.
| 2 min read
An innovative method for stripping greenhouse gases such as carbon dioxide from industrial emissions is potentially cheaper and more efficient than current methods, according to a United States patent based on research by Dr. Jason E. Bara, assistant professor of chemical and biological engineering at The University of Alabama.
| 3 min read
“Helper cells” improve survival rate of transplanted stem cells, mouse study finds.
| 3 min read
University of Washington researchers have performed what they believe is the first noninvasive human-to-human brain interface, with one researcher able to send a brain signal via the Internet to control the hand motions of a fellow researcher.
| 4 min read
This event will bring together research scientists, post docs, principal investigators, lab directors and professionals from around the world to learn about recent advances in cancer research.Available on Demand
Material deposit agreements established with over 30 institutions will accelerate biological material distribution to global research community.
| 2 min read
Scientists at The Scripps Research Institute (TSRI) have found a way to apply a powerful new DNA-editing technology more broadly than ever before.
| 4 min read
Haplogen, a biotechnology company developing antiviral therapies, and CeMM, the Center for Molecular Medicine of the Austrian Academy of Sciences, today announced that they are making available their large collection of human cell lines that are deficient for single genes, which they have been building over the past three years as part of a public-private partnership.
| 3 min read
